Lombard Odier Asset Management (Switzerland) Sa Care Dx, Inc. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$16.06 - $26.39 $808,717 - $1.33 Million	-50,356 Reduced 41.32%	71,523 $1.22 Million
Q2 2022 Aug 15, 2022	BUY	$20.49 - $39.72 $1.3 Million - $2.52 Million	63,327 Added 108.16%	121,879 $2.62 Million
Q1 2022 May 16, 2022	BUY	$28.19 - $46.6 $1.65 Million - $2.73 Million	58,552 New	58,552 $2.17 Million

Others Institutions Holding CDNA

# of Institutions

218

Shares Held

51.1M

Call Options Held

97.3K

Put Options Held

43.3K

Black Rock Inc. New York, NY

5.29M
Shares

$113 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.54M
Shares

$97.2 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.15M
Shares

$67.4 Million
1.65% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

2.99M
Shares

$64 Million
0.89% of portfolio
State Street Corp Boston, MA

2.04M
Shares

$43.6 Million
0.0% of portfolio

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account